Overview

Update
Status
Acquired by on January 7, 2010
Total Equity Funding
$26.1M in 5 Rounds from 2 Investors
Headquarters:
Paramus, NJ
Description:
AkaRx develops therapeutics including the orally-available small molecule for use in the treatment of thrombocytopenia.
Founders:
Categories:
Biopharma, Therapeutics, Biotechnology

Company Details

Update
Founded:
2005
Employees:
1 in Crunchbase

AkaRx, Inc., a biopharmaceutical company, develops therapeutic treatments for unmet medical needs. Its product includes AKR-501, an orally-available small molecule for use in the treatment of thrombocytopenia. The company was founded in 2005 and is headquartered in Paramus, New Jersey.

Funding Rounds (5) - $26.1M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jul, 2007$5M / Venture0
Feb, 2007$5M / Venture0
Oct, 2006$2M / Series A2
May, 2006$8.05M / Series A2
Aug, 2005$6.05M / Series A2

Current Team (1)

Update

Offices/Locations (1)

Update
  • Office

    Mack Centre IV

    4th Floor

    Paramus, NJ 07652

    USA

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos